Use of Mortality as an Endpoint in Noninferiority Trials May Lead to Ethically Problematic Conclusions

Journal of General Internal Medicine - Germany
doi 10.1007/s11606-018-4813-z
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC